Next Article in Journal
Factors Influencing Legionella Contamination of Domestic Household Showers
Previous Article in Journal
An Overview of the Most Significant Zoonotic Viral Pathogens Transmitted from Animal to Human in Saudi Arabia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 8
Issue 1
10.3390/pathogens8010026
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Evaluation of the Immune Responses in Cattle Mammary Tissues Naturally Infected with Bovine Parainfluenza Virus Type 3 and Bovine Alphaherpesvirus-1

by
Selim ÇOMAKLI
1,* and
Selçuk ÖZDEMİR
2
1
Department of Pathology, Faculty of Veterinary Medicine, Atatürk University, Yakutiye 25240, Erzurum, Turkey
2
Department of Genetics, Faculty of Veterinary Medicine, Atatürk University, Yakutiye 25240, Erzurum, Turkey
*
Author to whom correspondence should be addressed.
Pathogens 2019, 8(1), 26; https://doi.org/10.3390/pathogens8010026
Submission received: 8 January 2019 / Revised: 11 February 2019 / Accepted: 20 February 2019 / Published: 25 February 2019
(This article belongs to the Section Animal Pathogens)
Browse Figures
Versions Notes

Abstract

:
Bovine parainfluenza virus type 3 (BPIV-3) and Bovine alphaherpesvirus-1 (BoHV-1) lead to severe diseases in domesticated animals, such as Bovine, sheep, and goats. One of these diseases is mastitis, whose signs may not be observable in cases of viral infection due to the dominance of other clinical symptoms. This may lead to failure to predict viral agents in subclinical Bovine cases. Since viral infections have not been substantially investigated in mastitis studies, information about immune response to BPIV-3 and BoHV-1 infected Bovine mammary tissues may be inadequate. The present study aimed to determine the presence and prevalence of BPIV-3 and BoHV-1 agents in Bovine mammary tissues, and the immune response of such tissues against BPIV-3 and BoHV-1 infection. For this purpose, we first detected these viruses with qRT-PCR in mammary tissues. Then, we determined the expression profiles of interferon-γ (IFN-γ), CD4, and CD8 genes with qRT-PCR. Lastly, we performed immunohistochemistry staining to identify the presence of IFN-γ, CD4, and CD8 proteins in the mammary tissues. We found that 26, 16, and five of the 120 samples were BPI3-, BoHV1-, and BPIV-3 + BoHV-1 infected, respectively. Moreover, the gene expression levels of IFN-γ and CD4 were strongly up-regulated in the virus-infected tissues, whereas the CD8 gene expression level was only moderately up-regulated. Immunohistochemistry staining results were consistent with qRT-PCR results. Overall, our findings showed a high prevalence of BPIV-3 and BoHV-1 and indicated that cell-mediated immune response plays an important role against BPIV-3 and BoHV-1 infection in Bovine mammary tissues. Meanwhile, IFN-γ is an important cytokine for antiviral immunity against such infection.

1. Introduction

Mastitis is an inflammatory reaction of the parenchyma of the mammary gland. It can occur due to infectious, traumatic, or toxic agents and induce loss or reduction of milk yield [1,2]. In dairy animals, mastitis-causing pathogens are classified according to their epidemiological activity in infectious and environmental. Bacterial and non-bacterial pathogens, such as mycoplasms, fungi, yeasts, and chlamydia can lead to mastitis. Viruses take part in among the non-bacterial pathogens. Several viruses (including BoHV-1, BBovine herpes virus-4, foot-and-mouth disease virus, and BPIV-3) have been detected in milk from cows with clinical mastitis [3,4,5,6]. In addition, BoHV-1 and BPIV-3 have been observed in subclinical mastitis with no clinical findings [7].
The viral proteins are important for eliciting cellular immunity such as major glycoproteins, which play role in cell-mediated immunity [8] and for antibody-activated CD4+ T lymphocytes [9] or CD8+ cytotoxic lymphocytes [10,11]. CD4+ T helper (Th) cells serve as protective immune cells against intra-mammary infection as the major component of adaptive immune response. A previous study reported that mastitis caused the increasing of CD4+ cells in the milk of cattle [12]. CD4+ cells can secrete some cytokines, so they activate macrophages, CD8+ T cells, and B cells [13]. In mastitis, CD4+ T cells are mainly activated with recognition of complex molecules, which form between histocompatibility complex (MHC) II molecules or by antigen-presenting cells (APCs), B cells, and macrophages [13,14]. CD8+ T cells bind and clear off host cells, which are expressing foreign antigens related to MHC class I molecules. Suppressor CD8+ T cells play role in the immune response against bacterial infection [15].
Interferon-γ (IFN-γ) is the family of type II IFN and it is structurally not similar to type I IFNs, because it recognizes the different receptor, and is encoded by a different chromosomal locus. CD4+ cells, CD8+ cells, and NK cells particularly produce IFN-γ [16,17,18]. Besides, B cells, NKT cells, and professional APCs produce IFN-γ [19,20,21,22,23]. IFN-γ elevates the phagocytic capacity of neutrophils. Moreover, it was believed that IFN-γ is important in viral infections [24,25]. IFN-γ can lead to functional variation phagocytic cells in the mammary gland, thus it is an effective molecule in the control of Bovine mastitis [26,27].
The data obtained in the current study serves as a primary source for future studies of the pathogenesis of mastitis by determining the cellular immune responses to BoHV-1 and BPIV-3 in subclinical mastitis, which are manifest as single or mixed infections of cattle.

2. Results

2.1. Detection of Beta-Actin, BPIV-3, and BoHV-1 in Mammary Tissues

A ten-fold serial dilution of each of the total RNA was triplicate analyzed. All three targets were analyzed simultaneously and no evidence of cross reactivity between primers was detected. BPIV-3 agent was detected by the qRT-PCR in 26/120 samples, BoHV-1 agent in 16/120 samples. Coinfection with BPIV-3 and BoHV-1 was detected in 5/120 samples (Table 1). BPIV-3 and BoHV-1 infected tissues and their nucleic acid signals were shown in Figure S1. The expression satability of beta actin was demonstrated in Figure S2. In addition, the Ct/Cq values for BoHV-1 and BPIV-3 were given in the Table S1.

2.2. The Expression Profiles of IFN-γ, CD4, and CD8

The expression profiles of IFN, CD4, and CD8 genes were determined with qRT-PCR analysis. The mRNA transcript level of IFN was strongly up-regulated in the virus (BPIV-3, BoHV-1) infected samples compared to control (normal tissues). In the co-infected (BPIV-3 + BoHV-1) samples, IFN expression was similarly increased (Figure 1A). Similar to IFN gene expression profile, CD4 mRNA transcript level was up-regulated in all infected samples compared to control (Figure 1B). In contrast, the expression profile of CD8 was moderately up-regulated in all infected samples (Figure 1C).

2.3. Immunohistochemistry Staining

Immunohistologically detectable immune cells were observed in Bovine mammary tissues infected with BPIV-3 and BoHV-1. No T cell infiltration was found in mammary sections not infected with Bohv-1 or BPIV-3 (Figure 2A). There was an increase in the number of T cells in the infected mammary sections with these viruses (Figure 2B,C). CD8+ T cell immunoreactivity was found to be greater than CD4+ T cell immunoreactivity in BPIV-3 infected Bovine mammary tissues (Figure 3A and Figure 4A). CD4+ T cell immunoreactivity was found to be greater than CD8+ T cell immunoreactivity in BoHV-1 infected Bovine mammary tissues (Figure 3B and Figure 4B). Besides, CD4+ T cell immunoreactivity was found to be greater than CD8+ T cell immunoreactivity in the co-infections which occurred by both agents (Figure 3C and Figure 4C). IFN-γ immunoreactivity was observed as moderate in both BPIV-3 and BoHV-1 infections (Figure 5A,B). However, IFN-γ immunoreactivity was observed to be too intense in the co-infections which occurred by BPIV-3 and BoHV-1 (Figure 5C). Immunoreactivity of CD4+, CD8+ T cell, and IFN-γ was observed in lymphocytes in the interlobular and interalveolar areas.

2.4. Comparative Results

There were significant differences between all groups in terms of CD4+, CD8+ T cell, and IFN-γ (p < 0.05, Table 2). CD4+ T cells immunoreactivity increased in co-infection status when compared to BPIV-3 or BoHV-1 infections (p < 0.05, Table 3). CD8+ T cell immunoreactivity increased BPIV-3 and co-infection status when compared to BoHV-1 (p < 0.05, Table 2). There was no difference for IFN-γ immunoreactivity among BoHV-1 and BPIV-3 infection according to co-infections (p > 0.05, Table 2).

3. Discussion

The current study provides information about the presence and distribution of viral agents BPIV-3 and BoHV-1, and CD4, CD8, and IFN-γ responses to natural BPIV-3 and BoHV-1 infection in the mammary tissues of cattle. We found that 26, 16, and five samples were BPIV-3, BoHV-1, and BPIV-3 + BoHV-1 infected, respectively. Both CD4 and IFN-γ gene expressions were significantly up-regulated in the virus-infected tissues. In the co-infected (BPIV-3 + BoHV-1) tissues, the expression levels of CD4 and IFN-γ gene were strongly increased. By contrast, the CD8 gene expression level was only moderately increased in the virus-infected tissues relative to those of CD4 and IFN-γ. These results were confirmed via immunohistochemistry staining.
In qRT-PCR virus detection process, the accuracy of the data is ensured using positive control. However, positive control was not used in this study because of long process and biosafety precaution. In order to eliminate this limitation of the study, gel electrophoresis and melting curve analysis were performed. The consistency of the results indicates that the correct pcr products were detected.
Bovine mastitis disease induces important economic losses all over the world. Nonetheless, the number of studies on the presence and role of viral agents in mastitis cases remains low. BPIV-3 and BoHV-1 are the most important agents among viral pathogens shown to be responsible for mastitis cases [7,28]. Furthermore, the severity of disease is increased by various factors, such as stress, environmental conditions, and immunodeficiency. This disease occurs in many mammalian species, especially domestic dairy cows [29,30]. In previous studies, the presence and role of bacterial agents in mastitis cases are emphasized [30].
The recognition of viral antigens by T cells is essential for host defense against viral infection. T cells can bind to major MHC class I or class II molecules that are antigenic proteins at the cell surface. While CD8 T cells recognize MHC class I molecules, CD4 T cells recognize MHC class II molecules. CD8 T cells are referred to as cytolytic T lymphocytes (CTLs), and can produce cytokines. CD4 T cells can produce some cytokines that are important for the synthesis of antibodies and for the proliferation of CD8 T cells. Thus, they are referred to as Th cells. MHC class I and class II molecules play a role in the different pathways, including cytosolic and endosomal pathways, respectively. Therefore, CD8 CTLs eradicate intracellular pathogens, whereas CD4 helper T cells help to eliminate extracellular pathogens with B cells and cytokines [31]. Our findings indicated that BPV3 and BoHV infection in cattle mammary tissues induced an immune response activation of the CD4+ and CD8+ T cells. In addition, the higher CD4 gene expression level compared with that of CD8 showed that the endosomal pathway may be more active in the immune response in the case of BPIV-3 and BoHV-1 infection.
The IFNs, pro-inflammatory cytokines, were originally identified as cytokines that prevent viral replication. In addition, the IFN system provides the first response of immune defense against viral infections in vertebrates [32]. It can inhibit the viral infection by blocking virus replication and eliminating the virus-infected cells [33]. The type II family of IFNs includes a single member, interferon-γ (IFN-γ). IFN-γ has an effective role in innate and acquired immunity [34]. It has been reported that both CD4 and CD8 T cells are the primary sources of IFN-γ [35]. IFN-γ is an important cytokine that regulates several cellular processes through the transcriptional control of genes. Th1 cells that are essential for T cell-mediated immune response against intracellular infection are known to produce IFN-γ, TGF-β, and IL-2 cytokines, and are strongly associated with cell-mediated immunity inhibiting viral replication through the production of IFN-γ [35,36]. Th1 cytokines, including IL-2 and (IFN-γ), are strongly associated with directing cell-mediated immunity, such as by activation of macrophages [37]. In the present study, the increased IFN-γ expression level suggested that IFN-γ plays a role in the immune response against BPIV-3 and BoHV-1 infection in cattle mammary tissues. Furthermore, this result indicated that cell-mediated immunity is important in BPIV-3 and BoHV-1 infection.
Previous studies have reported that IFN-γ treatment can decrease viral titers in infected neuronal cells compared with untreated cells. It demonstrates that IFN-γ has potent antiviral activity [38]. In other cases of virus infection, including herpes simplex virus type 1, IFN-γ has been shown to limit transsynaptic transmission, prevent viral reactivation, and inhibit virally induced apoptosis [39,40,41]. CD8+ and CD4+ T cells have been shown to contribute to IFN-γ expression during a number of viral infections [42,43]. The common hypothesis has been that CD8+ T cell responses play active a role in antiviral immunity. While this remark is right for several viruses, recent studies show that CD4+ T cells also play role in the antiviral response [44,45,46,47,48,49,50]. Recent studies, including one in this issue, have shown the critical role of CD4 T cells in protection against viral infection [51]. The previous study has reported that CD4+ T cells are effectors for antiviral immunity due to secretion of key antiviral cytokines or direct cytotoxic effects [52]. The present study reports that in case of viral infection (BPIV-3 and BoHV-1), CD4, CD8, and IFN-γ gene expression levels were increased. This result indicated that CD4+ T cells, CD8+ T cells, and IFN-γ play a major role in antiviral immunity; this finding is supported by previous studies.
Because the immune response to BoHV-1 is not identical to that of herpes simplex virus in mice or in humans, the immune response of cattle to BoHV-1 infection is unique and does not correlate precisely with experimental BoHV-1 infection in mice [53,54]. The limiting cell type for antigen-induced proliferation in BoHV-1 infection is CD4+ T [55]. CD4+ T lymphocytes form primary cytolytic CD8+ T cells against some HSV-1 antigens [56,57]. CD8 T cell responses have been shown to be important mediators of immunity to a number of herpes virus infections. There is compelling evidence that CD8+ cells are required in preventing the reactivation of latent infection and that they also contribute to the resolution of the acute phase of infection [58,59]. The prominent role of CD8 T cells in immunity is also consistent with the capacity of herpes viruses, including BoHV-1, to inhibit a number of the steps involved in processing and presentation of antigen to CD8 T cells [60,61], thus reducing the efficiency of the CD8 T cell response [62]. Our findings revealed that BoHV-1 infection in mammary tissues causes the activation of CD4 and CD8.
While type I IFNs, especially IFN-α and IFN-β, are well-known in their antiviral role; some viruses restrict type I IFN production and responses. Previous studies have revealed that paramyxoviruses block type I IFN production and downstream signaling pathways [63,64]. A new class of IFNs, type III IFNs or IFN-λs, were described independently from two groups [65]. The recent study has reported that PIV-3 prevent the phosphorylation of Stat1 downstream of the type III IFN receptor [66]. CD4+ and CD8+ in PIV3 infected tissues produced Th1-polarized effector molecules, such as IFN-γ, TNF-α, and granzyme B, and they kill the antigen-loaded targets [67]. However, the effect of PIV-3 on the type II family of IFNs, IFN-γ, is unknown. In the present study, BPIV-3 infection increased the expression of IFN-γ in the mammary tissues of cattle. This result may be a new aspect for antiviral immunity against BPIV-3.

4. Material and Method

4.1. Material

The materials used in this study consisted of 120 cattle mammary tissues obtained from the Oral Meat Entegre Facility in Erzurum. The mammary tissue samples were obtained from 120 multiparous (between parities two and eight), Holstein (n = 120) dairy cows with no signs of inflammation of the mammary glands as macroscopic. Collected samples were brought to the laboratory for total RNA isolation procedures, real-time PCR, and immunohistochemistry staining.

4.2. Total RNA Isolation and cDNA Sythesis

Total RNA isolation was realized using TRIzol® (Invitrogen, Cat No: 15596026, USA). Mammary tissues (100 mg) were lysed and homogenized in 1mL Trizol reagent with a tissue homogenizer (Qiagen, TisueLyser II, Germany). Total RNA isolation process was performed in accordance with Trizol manufacturer procedure. The RNA concentration was measured using NanoDrop (Epoch Microplate Spectrophotometer, USA). The concentration of RNA samples was between 1250 ng/µL–1350 ng/µL. Total RNA samples quality were evaluated regarding DNA contamination by using gel electrophoresis. cDNA synthesis was performed using QuantiTect reverse transcription (Qiagen, Cat:330411 Germany). cDNA synthesis process was realized in accordance with kit’s manufacturer procedure.

4.3. Real Time PCR

Real-time quantitative PCR (RT-qPCR) was performed to identify BPIV-3, BoHV-1 virus and the gene expression of IFN, CD4, and CD8 in the mammary tissues with the CFX96 TouchTM Real-Time PCR Detection System (Bio-Rad, USA). β-Actin was used as a reference gene for RT-qPCR. Real-time PCR primers were designed in accordance with the sequence of cattle (Bos Taurus) using the primer design program Oligo 6.0 and Primer 5.0. IFN, CD4, and CD8 primer sequences and reaction conditions were shown in Table 3. BPIV-3 and BoHV-1 primer sequences and reaction conditions were also shown in Table 3 and these primer sequences were received from previously conducted studies [68,69]. Real-Time PCR was performed in a volume of 25 µL containing 12.5 µL 2x QuaniTect SYBR Green PCR Master Mix (Qiagen, Cat: 330500, Germany), which contained HotStart DNA Taq polymerase, 0.75 µL (5 µM) each primer, 0.75 µL (100 ng/µL) cDNA as a template, and 10.25 µL RNase and DNase free water. The PCR amplification was confirmed by agarose gel electrophoresis and melting curve analysis. Relative folds of expressions were assessed with the 2−ΔΔCT method [28]. The qRT-PCR assay was performed in accordance with the MIQE guidelines [70].

4.4. Immunohistochemistry Staining

After the routine histopathology processing, all samples were poured into paraffin for blocking and prepared microtome sections in 5 μm. After the deparaffinization of the tissues on the polylysine slide, the plates were incubated in 3% H2O2 to inactivate the endogenous peroxidase activity and washed with PBS. Then the slides were immersed in antigen retrieval solution (ab 96674, abcam, USA) (pH 6.0) and heated in a microwave for 10 min to unmasked antigens. After cooling, sections were incubated for 10 min with a protein block solution (ab 80436, Abcam, USA) to prevent nonspecific binding. Sections were incubated for immunohistochemistry staining with primer antibodies (CD8 antibody: Mouse anti Bovine CD8 antibody, clone CC63, MCA837GA, Bio-Rad (Formerly AbD Serotec), CD 4 antibody: Mouse anti Bovine CD4 antibody, MCA834GA by Bio-Rad (Formerly AbD Serotec), IFN-γ antibody: Mouse anti Bovine Interferon Gamma Antibody, MCA1964 by Bio-Rad (Formerly AbD Serotec)) at room temperature for 30 minutes. After incubation, the procedure specified by EXPOSE Mouse and Rabbit Specific HRP/DAB Detection IHC Kit (ab80436) was followed. Sections were incubated with 3.3 diaminobenzidine (DAB) and then counterstained with Mayer’s hematoxylin (MH). The immunoreactivity observed with light microscopy was semi-quantitatively estimated using the following scale: absent, 0; low reactivity, 1; intermediate reactivity, 2; or high reactivity, 3.

4.5. Statistical Analysis

IBM SPSS 20 was used to realize the statistical analyses. One-way analysis of variance was (ANOVA) used to detect statistical differences of IFGN, CD4, and CD8 expressions at mRNA transcript level between non-infected and infected mammary tissues. Relative mRNA fold change graphics were created by using the Graph pad prism software Inc., (Version 7.0, California, USA). qRT-PCR results are expressed as mean ± SEM (standard error of mean). Statistical differences were considered to be significant at p < 0.05, p < 0.01 and p < 0.001. For immunohistological, the differences among all groups were compared with nonparametric Kruskal–Wallis test. Dual cross-checks between the groups showing significant values were analyzed with a Mann–Whitney U-test (p < 0.05).

5. Conclusions

In conclusion, our findings indicated that natural BPIV-3 and BoHV-1 infections have a high prevalence in Bovine mammary tissues. This case revealed that significant precautions should be taken against viral agents in mastitis. In addition, it may be considered that the cellular immune response to viral infection is more active in BPIV-3 and BPIV-3 infected Bovine mammary tissues. Finally, this study demonstrates that IFN-γ is an important antiviral cytokine in BPIV-3 and BoHV-1 infections.

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-0817/8/1/26/s1, Figure S1: BPIV-3 and BoHV-1 nucleic acid signals, Figure S2: β-actin amplification signals for all tissues, Table S1: The Ct/Cq values of BoHV-1 and BPIV-3 for 120 samples.

Author Contributions

S.Ç. and S.Ö.: designed and performed the study and wrote the article; S.Ç.: performed the immunohistochemistry; S.Ö.: performed gene expression analysis.

Funding

This research received no external funding.

Acknowledgments

We thank Serdar ALTUN for technical assistance and the Eastern Anatolia Advanced Technology Application and Research Center (DAYTAM) for the instrumental support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. International Dairy Federation. Bovine Mastitis. Definitions and Guidelines for Diagnosis; International Dairy Federation: Brussels, Belgium, 1987; Volume 211, pp. 3–8. [Google Scholar]
  2. Vaarst, M.; Enevoldsen, C. Patterns of clinical mastitis manifestations in Danish organic dairy herds. J. Dairy Res. 1997, 64, 23–37. [Google Scholar] [CrossRef] [PubMed]
  3. Gourlay, R.E.J.; Espinasse, J.; Barle, C. Isolation of Mycoplasma agalactiae var bovis and infectious Bovine rhinotracheitis virus from an outbreak of mastitis in France. Vet. Rec. 1974, 95, 534–535. [Google Scholar] [CrossRef]
  4. Wellenberg, G.J.; van der Poel, W.H.; van der Vorst, T.J.; van Valkengoed, P.H.; Schukken, Y.H.; Wagenaar, F.; Van Oirschot, J.T. Bovine herpesvirus 4 in Bovine clinical mastitis. Vet. Rec. 2000, 147, 222–225. [Google Scholar] [CrossRef] [PubMed]
  5. Burrows, R.; Mann, J.A.; Greig, A.; Chapman, W.G.; Goodridge, D. The growth and persistence of foot-and-mouth disease virus in the Bovine mammary gland. J. Hyg. 1971, 69, 307–321. [Google Scholar] [CrossRef] [PubMed]
  6. Kawakami, Y.; Kaji, T.; Kume, T.; Omuro, M.; Hiramune, T.; Murase, N.; Matumoto, M. Infection of cattle with parainfluenza 3 virus with special reference to udder infection. I. Virus isolation from milk. Jpn. J. Microbiol. 1966, 10, 159–169. [Google Scholar] [CrossRef] [PubMed]
  7. Wellenberg, G.J.; van der Poel, W.H.; Van Oirschot, J.T. Viral infections and Bovine mastitis: A review. Vet. Microbiol. 2002, 88, 27–45. [Google Scholar] [CrossRef]
  8. Hutchings, D.; Babiuk, L. Lymphocyte proliferative responses to separated Bovine herpesvirus 1 proteins in immune cattle. J. Virol. 1990, 64, 5114–5122. [Google Scholar] [PubMed]
  9. Choi, S.-H.; Splitter, G.A. Induction of MHC-unrestricted cytolytic CD4+ T cells against virally infected target cells by cross-linking CD4 molecules. J. Immunol. 1994, 153, 3874–3881. [Google Scholar] [PubMed]
  10. Denis, M.; Slaoui, M.; Keil, G.; Babiuk, L.; Ernst, E.; Pastoret, P.-P.; Thiry, E. Identification of different target glycoproteins for Bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 1993, 78, 7. [Google Scholar] [PubMed]
  11. Turin, L.; Russo, S.; Poli, G. BHV-1: New molecular approaches to control a common and widespread infection. Mol. Med. 1999, 5, 261. [Google Scholar] [CrossRef] [PubMed]
  12. Banos, G.; Wall, E.; Coffey, M.P.; Bagnall, A.; Gillespie, S.; Russell, G.C.; McNeilly, T.N. Identification of immune traits correlated with dairy cow health, reproduction and productivity. PLoS ONE 2013, 8, e65766. [Google Scholar] [CrossRef] [PubMed]
  13. Sordillo, L.; Shafer-Weaver, K.; DeRosa, D. Immunobiology of the mammary gland. J. Dairy Sci. 1997, 80, 1851–1865. [Google Scholar] [CrossRef]
  14. Park, Y.H.; Park, J.Y.; Kim, S.H.; Ahn, J.S.; Davies, C.J. Characterization of lymphocyte subpopulations and major histocompatibility complex haplotypes of mastitis-resistant and susceptible cows. J. Vet. Sci. 2004, 5, 29–39. [Google Scholar] [CrossRef] [PubMed]
  15. Oviedo-Boyso, J.; Valdez-Alarcón, J.J.; Cajero-Juárez, M.; Ochoa-Zarzosa, A.; López-Meza, J.E.; Bravo-Patino, A.; Baizabal-Aguirre, V.M. Innate immune response of Bovine mammary gland to pathogenic bacteria responsible for mastitis. J. Infect. 2007, 54, 399–409. [Google Scholar] [CrossRef] [PubMed]
  16. Bach, E.A.; Aguet, M.; Schreiber, R.D. The IFNγ receptor: A paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 1997, 15, 563–591. [Google Scholar] [CrossRef] [PubMed]
  17. Jonasch, E.; Haluska, F.G. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities. Oncologist 2001, 6, 34–55. [Google Scholar] [CrossRef] [PubMed]
  18. Young, H.A. Regulation of interferon-γ gene expression. J. Interf. Cytokine res. 1996, 16, 563–568. [Google Scholar] [CrossRef] [PubMed]
  19. Carnaud, C.; Lee, D.; Donnars, O.; Park, S.-H.; Beavis, A.; Koezuka, Y.; Bendelac, A. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999, 163, 4647–4650. [Google Scholar] [PubMed]
  20. Frucht, D.M.; Fukao, T.; Bogdan, C.; Schindler, H.; O’Shea, J.J.; Koyasu, S. IFN-γ production by antigen-presenting cells: Mechanisms emerge. Trends Immunol. 2001, 22, 556–560. [Google Scholar] [CrossRef]
  21. Flaishon, L.; Hershkoviz, R.; Lantner, F.; Lider, O.; Alon, R.; Levo, Y.; Flavell, R.A.; Shachar, I. Autocrine secretion of interferon γ negatively regulates homing of immature B cells. J. Exp. Med. 2000, 192, 1381–1388. [Google Scholar] [CrossRef] [PubMed]
  22. Harris, D.P.; Haynes, L.; Sayles, P.C.; Duso, D.K.; Eaton, S.M.; Lepak, N.M.; Johnson, L.L.; Swain, S.L.; Lund, F.E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 2000, 1, 475. [Google Scholar] [CrossRef] [PubMed]
  23. Schroder, K.; Hertzog, P.J.; Ravasi, T.; Hume, D.A. Interferon-γ: An overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75, 163–189. [Google Scholar] [CrossRef] [PubMed]
  24. Shtrichman, R.; Samuel, C.E. The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 2001, 4, 251–259. [Google Scholar] [CrossRef]
  25. Nonnecke, B.; Kimura, K.; Goff, J.; Kehrli, M. Effects of the Mammary Gland on Functional Capacities of Blood Mononuclear Leukocyte Populations from Periparturient Cows1. J. Dairy Sci. 2003, 86, 2359–2368. [Google Scholar] [CrossRef]
  26. Sordillo, L.M.; Babiuk, L.A. Controlling acute Escherichia coli mastitis during the periparturient period with recombinant Bovine interferon gamma. Vet. Microbiol. 1991, 28, 189–198. [Google Scholar] [CrossRef]
  27. Sordillo, L.M.; Babiuk, L.A. Modulation of Bovine mammary neutrophil function during the periparturient period following in vitro exposure to recombinant Bovine interferon gamma. Vet. Immunol. Immunop. 1991, 27, 393–402. [Google Scholar] [CrossRef]
  28. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
  29. Petrovski, K.R.; Trajcev, M.; Buneski, G. A review of the factors affecting the costs of Bovine mastitis. J. S. Afr. Vet. Assoc. 2006, 77, 52–60. [Google Scholar] [CrossRef] [PubMed]
  30. Gomes, F.; Henriques, M. Control of Bovine Mastitis: Old and Recent Therapeutic Approaches. Curr. Microbiol. 2016, 72, 377–382. [Google Scholar] [CrossRef] [PubMed]
  31. Koszinowski, U.H.; Reddehase, M.J.; Jonjic, S. The role of CD4 and CD8 T cells in viral infections. Curr. Opin. Immunol. 1991, 3, 471–475. [Google Scholar] [CrossRef]
  32. Fensterl, V.; Chattopadhyay, S.; Sen, G.C. No Love Lost Between Viruses and Interferons. Annu. Rev. Virol. 2015, 2, 549–572. [Google Scholar] [CrossRef] [PubMed]
  33. Chan, Y.K.; Gack, M.U. RIG-I-like receptor regulation in virus infection and immunity. Curr. Opin. Virol. 2015, 12, 7–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Farrar, M.A.; Schreiber, R.D. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 1993, 11, 571–611. [Google Scholar] [CrossRef] [PubMed]
  35. Ngai, P.; McCormick, S.; Small, C.; Zhang, X.; Zganiacz, A.; Aoki, N.; Xing, Z. Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection. Infect. Immun. 2007, 75, 2244–2252. [Google Scholar] [CrossRef] [PubMed]
  36. Ayari-Fakhfakh, E.; Ghram, A.; Albina, E.; Cetre-Sossah, C. Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins. Vet. Immunol. Immunopathol. 2018, 197, 15–20. [Google Scholar] [CrossRef] [PubMed]
  37. Reed, J.R.; Schwertfeger, K.L. Immune cell location and function during post-natal mammary gland development. J. Mammary Gland Biol. Neoplasia 2010, 15, 329–339. [Google Scholar] [CrossRef] [PubMed]
  38. Komatsu, T.; Bi, Z.; Reiss, C.S. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 1996, 68, 101–108. [Google Scholar] [CrossRef]
  39. Mikloska, Z.; Cunningham, A.L. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 2001, 75, 11821–11826. [Google Scholar] [CrossRef] [PubMed]
  40. Cantin, E.; Tanamachi, B.; Openshaw, H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 1999, 73, 3418–3423. [Google Scholar] [PubMed]
  41. Geiger, K.D.; Gurushanthaiah, D.; Howes, E.L.; Lewandowski, G.A.; Reed, J.C.; Bloom, F.E.; Sarvetnick, N.E. Cytokine-mediated survival from lethal herpes simplex virus infection: Role of programmed neuronal death. Proc. Natl. Acad. Sci. USA 1995, 92, 3411–3415. [Google Scholar] [CrossRef] [PubMed]
  42. Sarawar, S.R.; Carding, S.R.; Allan, W.; McMickle, A.; Fujihashi, K.; Kiyono, H.; McGhee, J.R.; Doherty, P.C. Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: Consequences of CD4+ and CD8+ T cell depletion. Reg. Immunol. 1993, 5, 142–150. [Google Scholar] [PubMed]
  43. Graziosi, C.; Pantaleo, G.; Gantt, K.R.; Fortin, J.P.; Demarest, J.F.; Cohen, O.J.; Sekaly, R.P.; Fauci, A.S. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994, 265, 248–252. [Google Scholar] [CrossRef] [PubMed]
  44. Soghoian, D.Z.; Streeck, H. Cytolytic CD4(+) T cells in viral immunity. Expert Rev. Vaccines 2010, 9, 1453–1463. [Google Scholar] [CrossRef] [PubMed]
  45. Porichis, F.; Kaufmann, D.E. HIV-specific CD4 T cells and immune control of viral replication. Curr. Opin. HIV AIDS 2011, 6, 174–180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Theze, J.; Chakrabarti, L.A.; Vingert, B.; Porichis, F.; Kaufmann, D.E. HIV controllers: A multifactorial phenotype of spontaneous viral suppression. Clin. Immunol. 2011, 141, 15–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Brown, D.M.; Lee, S.; Garcia-Hernandez Mde, L.; Swain, S.L. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 2012, 86, 6792–6803. [Google Scholar] [CrossRef] [PubMed]
  48. Ranasinghe, S.; Flanders, M.; Cutler, S.; Soghoian, D.Z.; Ghebremichael, M.; Davis, I.; Lindqvist, M.; Pereyra, F.; Walker, B.D.; Heckerman, D.; et al. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J. Virol. 2012, 86, 277–283. [Google Scholar] [CrossRef] [PubMed]
  49. Soghoian, D.Z.; Jessen, H.; Flanders, M.; Sierra-Davidson, K.; Cutler, S.; Pertel, T.; Ranasinghe, S.; Lindqvist, M.; Davis, I.; Lane, K.; et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci. Transl. Med. 2012, 4, 123–125. [Google Scholar] [CrossRef] [PubMed]
  50. Wilkinson, T.M.; Li, C.K.; Chui, C.S.; Huang, A.K.; Perkins, M.; Liebner, J.C.; Lambkin-Williams, R.; Gilbert, A.; Oxford, J.; Nicholas, B.; et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 2012, 18, 274–280. [Google Scholar] [CrossRef] [PubMed]
  51. Zhou, Y.; Callendret, B.; Xu, D.; Brasky, K.M.; Feng, Z.; Hensley, L.L.; Guedj, J.; Perelson, A.S.; Lemon, S.M.; Lanford, R.E.; et al. Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. J. Exp. Med. 2012, 209, 1481–1492. [Google Scholar] [CrossRef] [PubMed]
  52. Swain, S.L.; McKinstry, K.K.; Strutt, T.M. Expanding roles for CD4(+) T cells in immunity to viruses. Nat. Rev. Immunol. 2012, 12, 136–148. [Google Scholar] [CrossRef] [PubMed]
  53. Babiuk, L.A.; van Drunen Littel-van den Hurk, S.; Tikoo, S.K. Immunology of Bovine herpesvirus 1 infection. Vet. Microbiol. 1996, 53, 31–42. [Google Scholar] [CrossRef]
  54. Biswas, S.; Bandyopadhyay, S.; Dimri, U.; Patra, P.H. Bovine herpesvirus-1 (BHV-1)—A re-emerging concern in livestock: A revisit to its biology, epidemiology, diagnosis, and prophylaxis. Vet. Q. 2013, 33, 68–81. [Google Scholar] [CrossRef] [PubMed]
  55. Weynants, V.; Walravens, K.; Didembourg, C.; Flanagan, P.; Godfroid, J.; Letesson, J.J. Quantitative assessment by flow cytometry of T-lymphocytes producing antigen-specific gamma-interferon in Brucella immune cattle. Vet. Immunol. Immunopathol. 1998, 66, 309–320. [Google Scholar] [CrossRef]
  56. Hu, Z.; Molloy, M.J.; Usherwood, E.J. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Cell. Mol. Immunol. 2016, 13, 82–93. [Google Scholar] [CrossRef] [PubMed]
  57. Winkler, M.T.; Doster, A.; Jones, C. Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle. J. Virol. 1999, 73, 8657–8668. [Google Scholar] [PubMed]
  58. Liu, T.; Khanna, K.M.; Chen, X.; Fink, D.J.; Hendricks, R.L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 2000, 191, 1459–1466. [Google Scholar] [CrossRef] [PubMed]
  59. Divito, S.; Cherpes, T.L.; Hendricks, R.L. A triple entente: Virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol. Res. 2006, 36, 119–126. [Google Scholar] [CrossRef]
  60. Burrows, S.R.; Moss, D.J.; Khanna, R. Understanding human T-cell-mediated immunoregulation through herpesviruses. Immunol. Cell Biol. 2011, 89, 352–358. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Verweij, M.C.; Horst, D.; Griffin, B.D.; Luteijn, R.D.; Davison, A.J.; Ressing, M.E.; Wiertz, E.J. Viral inhibition of the transporter associated with antigen processing (TAP): A striking example of functional convergent evolution. PLoS Pathog. 2015, 11, e1004743. [Google Scholar] [CrossRef] [PubMed]
  62. Hart, J.; MacHugh, N.D.; Sheldrake, T.; Nielsen, M.; Morrison, W.I. Identification of immediate early gene products of Bovine herpes virus 1 (BHV-1) as dominant antigens recognized by CD8 T cells in immune cattle. J. Gen. Virol. 2017, 98, 1843–1854. [Google Scholar] [CrossRef] [PubMed]
  63. Andrejeva, J.; Childs, K.S.; Young, D.F.; Carlos, T.S.; Stock, N.; Goodbourn, S.; Randall, R.E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 2004, 101, 17264–17269. [Google Scholar] [CrossRef] [PubMed]
  64. Yamaguchi, M.; Kitagawa, Y.; Zhou, M.; Itoh, M.; Gotoh, B. An anti-interferon activity shared by paramyxovirus C proteins: Inhibition of Toll-like receptor 7/9-dependent alpha interferon induction. FEBS Lett. 2014, 588, 28–34. [Google Scholar] [CrossRef] [PubMed]
  65. Kotenko, S.V.; Gallagher, G.; Baurin, V.V.; Lewis-Antes, A.; Shen, M.; Shah, N.K.; Langer, J.A.; Sheikh, F.; Dickensheets, H.; Donnelly, R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4, 69–77. [Google Scholar] [CrossRef] [PubMed]
  66. Eberle, K.C.; McGill, J.L.; Reinhardt, T.A.; Sacco, R.E. Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation. J. Virol. 2015, 90, 2948–2958. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Aguayo-Hiraldo, P.I.; Arasaratnam, R.J.; Tzannou, I.; Kuvalekar, M.; Lulla, P.; Naik, S.; Martinez, C.A.; Piedra, P.A.; Vera, J.F.; Leen, A.M. Characterizing the Cellular Immune Response to Parainfluenza Virus 3. J. Infect. Dis. 2017, 216, 153–161. [Google Scholar] [CrossRef] [PubMed]
  68. Kubis, P.; Materniak, M.; Kuzmak, J. Comparison of nested PCR and qPCR for the detection and quantitation of BoHV6 DNA. J. Virol. Methods 2013, 194, 94–101. [Google Scholar] [CrossRef] [PubMed]
  69. Thonur, L.; Maley, M.; Gilray, J.; Crook, T.; Laming, E.; Turnbull, D.; Nath, M.; Willoughby, K. One-step multiplex real time RT-PCR for the detection of Bovine respiratory syncytial virus, Bovine herpesvirus 1 and Bovine parainfluenza virus 3. BMC Vet. Res. 2012, 8, 37. [Google Scholar] [CrossRef] [PubMed]
  70. Bustin, S.A.; Benes, V.; Garson, J.A.; Hellemans, J.; Huggett, J.; Kubista, M.; Mueller, R.; Nolan, T.; Pfaffl, M.W.; Shipley, G.L.; et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55, 611–622. [Google Scholar] [CrossRef] [PubMed]
Pathogens 08 00026 g001 550
Figure 1. The mRNA transcript levels of IFN-γ, CD4, and CD8 genes in natural BPIV-3 and BoHV-1 infected mammary tissues of cattle. Values represent the mean ± SD of three independent samples; error bars indicate standard deviation. Statistical significance (* p ˂ 0.05, ** p < 0.01 and *** p < 0.001) was analyzed using a one-way ANOVA. (A) Represent the relative mRNA expression levels of IFN-γ gene. (B) Represent the relative mRNA expression levels of CD4 gene. (C) Represent the relative mRNA expression levels of CD8 gene.
Figure 1. The mRNA transcript levels of IFN-γ, CD4, and CD8 genes in natural BPIV-3 and BoHV-1 infected mammary tissues of cattle. Values represent the mean ± SD of three independent samples; error bars indicate standard deviation. Statistical significance (* p ˂ 0.05, ** p < 0.01 and *** p < 0.001) was analyzed using a one-way ANOVA. (A) Represent the relative mRNA expression levels of IFN-γ gene. (B) Represent the relative mRNA expression levels of CD4 gene. (C) Represent the relative mRNA expression levels of CD8 gene.
Pathogens 08 00026 g001
Pathogens 08 00026 g002 550
Figure 2. Comparison of positive and negative sections in terms of BPIV-3 and BoHV-1 virus in Bovine mammary tissue using paraffin-embedded sections (A–C): (A) Negative mammary section in terms of BPIV-3 and BoHV-1. Immunohistochemistry (IHC). Bar, 40 μm. (B) Positive T cell infiltration (star) in BPIV-3 infected mammary section. IHC. Bar, 20 μm. (C) Positive T cell infiltration (star) in BoHV-1 infected mammary section. IHC. Bar, 40 μm.
Figure 2. Comparison of positive and negative sections in terms of BPIV-3 and BoHV-1 virus in Bovine mammary tissue using paraffin-embedded sections (A–C): (A) Negative mammary section in terms of BPIV-3 and BoHV-1. Immunohistochemistry (IHC). Bar, 40 μm. (B) Positive T cell infiltration (star) in BPIV-3 infected mammary section. IHC. Bar, 20 μm. (C) Positive T cell infiltration (star) in BoHV-1 infected mammary section. IHC. Bar, 40 μm.
Pathogens 08 00026 g002
Pathogens 08 00026 g003 550
Figure 3. Immunohistochemical staining of CD8 + T cells of the Bovine mammary tissue using paraffin-embedded sections (A–C): (A) The intermediate immunoreactivity of CD8 + T lymphocytes (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD8+ T cells in Bovine mammary tissue infected with BPIV-3. (B) The low immunoreactivity of T lymphocytes (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD8+ T cells in Bovine mammary tissue infected with BoHV-1. (C) The high reactivity distributional of T lymphocytes in the interalveolar connective tissue with the monoclonal antibody specific for CD8+ T cells (arrow) in Bovine mammary tissue infected with BoHV-1 and BPIV-3. IHC. Bar, 20 μm.
Figure 3. Immunohistochemical staining of CD8 + T cells of the Bovine mammary tissue using paraffin-embedded sections (A–C): (A) The intermediate immunoreactivity of CD8 + T lymphocytes (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD8+ T cells in Bovine mammary tissue infected with BPIV-3. (B) The low immunoreactivity of T lymphocytes (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD8+ T cells in Bovine mammary tissue infected with BoHV-1. (C) The high reactivity distributional of T lymphocytes in the interalveolar connective tissue with the monoclonal antibody specific for CD8+ T cells (arrow) in Bovine mammary tissue infected with BoHV-1 and BPIV-3. IHC. Bar, 20 μm.
Pathogens 08 00026 g003
Pathogens 08 00026 g004 550
Figure 4. Immunohistochemical staining of CD4 + T cells of the Bovine mammary tissue using paraffin-embedded sections (A–C): (A) Showing the low immunoreactivity of T lymphocytes (arrow) in the interlobular connective tissue with the monoclonal antibody specific for CD4+ T cells in Bovine mammary tissue infected with BPIV-3. (B) The intermediate immunoreactivity of CD4 + T cells (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD4+ T cells in Bovine mammary tissue infected with BoHV-1. (C) The high reactivity distributional of CD4 + T lymphocytes (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD4+ T cells in Bovine mammary tissue infected with BoHV-1 and BPIV-3. IHC. Bar, 20 μm.
Figure 4. Immunohistochemical staining of CD4 + T cells of the Bovine mammary tissue using paraffin-embedded sections (A–C): (A) Showing the low immunoreactivity of T lymphocytes (arrow) in the interlobular connective tissue with the monoclonal antibody specific for CD4+ T cells in Bovine mammary tissue infected with BPIV-3. (B) The intermediate immunoreactivity of CD4 + T cells (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD4+ T cells in Bovine mammary tissue infected with BoHV-1. (C) The high reactivity distributional of CD4 + T lymphocytes (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for CD4+ T cells in Bovine mammary tissue infected with BoHV-1 and BPIV-3. IHC. Bar, 20 μm.
Pathogens 08 00026 g004
Pathogens 08 00026 g005 550
Figure 5. Immunohistochemical staining of IFN-γ in the Bovine mammary tissue using paraffin-embedded sections (A–C): (A) The intermediate immunoreactivity of IFN-γ (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for IFN-γ in Bovine mammary tissue infected with BPIV-3. (B) The intermediate immunoreactivity of IFN-γ (arrow) in the interlobular connective tissue with the monoclonal antibody specific for IFN-γ in Bovine mammary tissue infected with BoHV-1. (C) The high immunoreactivity of IFN-γ (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for IFN-γ in Bovine mammary tissue infected with BoHV-1 and BPIV-3. IHC. Bar, 20 μm.
Figure 5. Immunohistochemical staining of IFN-γ in the Bovine mammary tissue using paraffin-embedded sections (A–C): (A) The intermediate immunoreactivity of IFN-γ (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for IFN-γ in Bovine mammary tissue infected with BPIV-3. (B) The intermediate immunoreactivity of IFN-γ (arrow) in the interlobular connective tissue with the monoclonal antibody specific for IFN-γ in Bovine mammary tissue infected with BoHV-1. (C) The high immunoreactivity of IFN-γ (arrow) in the interalveolar connective tissue with the monoclonal antibody specific for IFN-γ in Bovine mammary tissue infected with BoHV-1 and BPIV-3. IHC. Bar, 20 μm.
Pathogens 08 00026 g005
Table
Table 1. Real time RT-PCR results for 120 samples.
Table 1. Real time RT-PCR results for 120 samples.
MaterialBPIV-3BoHV-1BPIV-3 and BoHV-1
Macroscopic lesionsAbsenceAbsenceAbsence
Mammary tissue26165
Percentage (%)21.66%13.3%4.16%
Table
Table 2. Immunoreactivity scale (mean + Std) of CD4+, CD8+ and IFN-γ in the mammarian tissue of five Bovine mammary tissues which is infected with BPIV-3 and BoHV-1. Means with the different letter, per each column, are significantly different according to Mann–Whitney U test, p < 0.05.
Table 2. Immunoreactivity scale (mean + Std) of CD4+, CD8+ and IFN-γ in the mammarian tissue of five Bovine mammary tissues which is infected with BPIV-3 and BoHV-1. Means with the different letter, per each column, are significantly different according to Mann–Whitney U test, p < 0.05.
N = 5CD4 + T cellsCD8 + T cellsIFN-γ
BPIV-30.80 ± 0.44 a2.20 ± 0.44 b1.40 ± 0.89 c
BoHV-11.66 ± 0.51 aı1.00 ± 1.09 bı1.66 ± 1.03 cı
BPIV-3 + BoHV-12.75 ± 0.50 aıı2.75 ± 0.50 aıı2.75 ± 0.50 cıı
Means with the different letter and number per each column, are significantly different according to Mann–Whitney U test, p < 0.05.
Table
Table 3. Pimer sequences of Beta Actin, IFN-γ, CD4, CD8, BPIV-3, and BoHV-1.
Table 3. Pimer sequences of Beta Actin, IFN-γ, CD4, CD8, BPIV-3, and BoHV-1.
Gene NamePrimer SequenceAmplicon Size (bp)Accession NoReaction Conditions
Bo-IFN-γF - AATTCCGGTGGATGATCTGC
R - TCTCCGGCCTCGAAAGAGAT		130NM_174086.194 °C 15 s/55 °C 30 s/72 °C 30 s (40 cycles)
Bo-CD4F - TGATGAAAGTGACTAAGTCCCCA
R- TTCGGCTGATTTGAGCCCTT		121NM_001103225.194 °C 15 s/58 °C 30 s/72 °C 30 s (40 cycles)
Bo-CD8F - CTGGACTTCGCCTGCAATATC
R- CACGTCTTCGGTTCCGGC		112NM_174015.194 °C 15 s/57 °C 30 s/72 °C 30 s (40 cycles)
Bo-Beta ActinF - GTCGACACCGCAACCAGTTC
R - TACGAGTCCTTCTGGCCCAT		181AY141970.194 °C 15 s/57 °C 30 s/72 °C 30 s (40 cycles)
Gene NamePrimer SequencesReferenceReactions Conditions
BPIV-3F: TGATTGGATGTTCGGGAGTGA
R: AGAATCCTTTCCTCAATCCTGATATACT		[28]94 °C for 15 s, 58 °C for 30 s/72 °C for 30 s (40 cycle)
BoHV-1F: TGTGGACCTAAACCTCACGGT
R: GTAGTCGAGCAGACCCGTGTC		[28]94 °C for 15 s, 59 °C for 30 s/72 °C for 30 s (40 cycle)

Share and Cite

MDPI and ACS Style

ÇOMAKLI, S.; ÖZDEMİR, S. Comparative Evaluation of the Immune Responses in Cattle Mammary Tissues Naturally Infected with Bovine Parainfluenza Virus Type 3 and Bovine Alphaherpesvirus-1. Pathogens 2019, 8, 26. https://doi.org/10.3390/pathogens8010026

AMA Style

ÇOMAKLI S, ÖZDEMİR S. Comparative Evaluation of the Immune Responses in Cattle Mammary Tissues Naturally Infected with Bovine Parainfluenza Virus Type 3 and Bovine Alphaherpesvirus-1. Pathogens. 2019; 8(1):26. https://doi.org/10.3390/pathogens8010026

Chicago/Turabian Style

ÇOMAKLI, Selim, and Selçuk ÖZDEMİR. 2019. "Comparative Evaluation of the Immune Responses in Cattle Mammary Tissues Naturally Infected with Bovine Parainfluenza Virus Type 3 and Bovine Alphaherpesvirus-1" Pathogens 8, no. 1: 26. https://doi.org/10.3390/pathogens8010026

APA Style

ÇOMAKLI, S., & ÖZDEMİR, S. (2019). Comparative Evaluation of the Immune Responses in Cattle Mammary Tissues Naturally Infected with Bovine Parainfluenza Virus Type 3 and Bovine Alphaherpesvirus-1. Pathogens, 8(1), 26. https://doi.org/10.3390/pathogens8010026

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop